0001209191-18-063579.txt : 20181219
0001209191-18-063579.hdr.sgml : 20181219
20181219190747
ACCESSION NUMBER: 0001209191-18-063579
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20181217
FILED AS OF DATE: 20181219
DATE AS OF CHANGE: 20181219
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: HOMCY CHARLES J
CENTRAL INDEX KEY: 0001192591
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35935
FILM NUMBER: 181244414
MAIL ADDRESS:
STREET 1: PORTOLA PHARMACEUTICALS, INC.
STREET 2: 270 EAST GRAND AVENUE
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: PORTOLA PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0001269021
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 270 EAST GRAND AVENUE, SUITE 22
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: 650-244-6864
MAIL ADDRESS:
STREET 1: 270 EAST GRAND AVENUE, SUITE 22
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2018-12-17
0
0001269021
PORTOLA PHARMACEUTICALS INC
PTLA
0001192591
HOMCY CHARLES J
C/O PORTOLA PHARMACEUTICALS, INC.
270 EAST GRAND AVE.
SOUTH SAN FRANCISCO
CA
94080
1
0
0
0
Common Stock
2018-12-17
4
M
0
64218
4.10
A
176689
D
Common Stock
2018-12-17
4
S
0
63518
18.602
D
113171
D
Common Stock
2018-12-17
4
S
0
700
19.20
D
112471
D
Common Stock
2018-12-19
4
M
0
25782
4.10
A
119480
I
Charles Homcy Revocable Trust
Common Stock
20000
I
The Charles J. Homcy 2009 Grantor Retained Annuity Trust
Stock Option (Right to Buy)
4.10
2018-12-17
4
M
0
24390
0.00
D
2008-12-23
2018-12-22
Common Stock
24390
0
D
Stock Option (Right to Buy)
4.10
2018-12-17
4
M
0
39828
0.00
D
2008-12-23
2018-12-22
Common Stock
39828
25782
D
Stock Option (Right to Buy)
4.10
2018-12-19
4
M
0
25782
0.00
D
2008-12-23
2018-12-22
Common Stock
25782
0
D
The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 7, 2018.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.2000 to $19.1900, inclusive.
These sales were sold in a single transaction at a price of $19.20.
Dr. Homcy exercised these shares through a cash exercise and transferred the shares following the exercise into the Charles Homcy Revocable Trust for which Dr. Homcy is a trustee.
/s/ Mike Ouimette, as attorney-in-fact
2018-12-19